106 results
Keyword paclitaxel Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Pazenir
paclitaxel, Breast Neoplasms
Date of authorisation: 06/05/2019,
, Revision: 5, Authorised, Last updated: 24/06/2020
Authorised paclitaxel Overview Pazenir is used … medicine. active substance paclitaxel attached to a human protein … other medicines containing paclitaxel. The medicine can only be … -
List item
Human medicine European public assessment report (EPAR): Abraxane
paclitaxel, Breast Neoplasms, Pancreatic Neoplasms, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 11/01/2008, Revision: 26, Authorised, Last updated: 09/03/2020Abraxane, INN-paclitaxel 30 Churchill Place … for the public Abraxane paclitaxel This document is a summary … contains the active substance paclitaxel attached to a human protein … -
List item
Human medicine European public assessment report (EPAR): Apealea
paclitaxel, Ovarian Neoplasms
Date of authorisation: 20/11/2018, Revision: 3, Authorised, Last updated: 04/03/2020authorisation) Apealea paclitaxel On 20 September 2018, the … substance of Apealea is paclitaxel, an antineoplastic agent that … ‘taxanes’ (ATC code: L01CD01). Paclitaxel blocks a stage of cell division … -
List item
Human medicine European public assessment report (EPAR): Paxene
paclitaxel, Sarcoma, Kaposi, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Breast Neoplasms
Date of authorisation: 19/07/1999, Revision: 14, Withdrawn, Last updated: 22/03/2010Public statement on Paxene (paclitaxel) Withdrawal of the marketing … medicinal product Paxene, paclitaxel, which had been approved for … EMEA/H/C/216 Paxene paclitaxel EPAR summary for the … -
List item
Human medicine European public assessment report (EPAR): Avastin
bevacizumab, Carcinoma, Non-Small-Cell Lung, Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Carcinoma, Renal Cell
Date of authorisation: 12/01/2005, Revision: 55, Authorised, Last updated: 24/06/2020used in combination with paclitaxel (an anticancer medicine belonging … combination with the taxane paclitaxel. This follows a review1 of … cancer, in combination with paclitaxel or capecitabine; advanced … -
List item
Human medicine European public assessment report (EPAR): Tecentriq
atezolizumab, Carcinoma, Transitional Cell, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2017,
, Revision: 11, Authorised, Last updated: 19/10/2020
given Tecentriq together with paclitaxel, carboplatin and bevacizumab … getting worse while those given paclitaxel, carboplatin and bevacizumab … with carboplatin plus nab-paclitaxel compared with 13.9 months … -
List item
Human medicine European public assessment report (EPAR): Mvasi (updated)
bevacizumab, Carcinoma, Renal Cell, Peritoneal Neoplasms, Ovarian Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms
Date of authorisation: 15/01/2018,, 
, Revision: 9, Authorised, Last updated: 03/11/2020
medicines carboplatin and paclitaxel. The cancer responded to treatment … -
List item
Human medicine European public assessment report (EPAR): Herceptin
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 28/08/2000, Revision: 38, Authorised, Last updated: 27/08/2020anticancer medicines: with paclitaxel or docetaxel, or with an … Herceptin in combination with paclitaxel or docetaxel in a total of … used in combination with paclitaxel or docetaxel, around half … -
List item
Human medicine European public assessment report (EPAR): Aybintio
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 19/08/2020,, Authorised, Last updated: 02/09/2020
Aybintio in combination with paclitaxel is indicated for first-line … combination with carboplatin and paclitaxel is indicated for the front-line … combination with carboplatin and paclitaxel, is indicated for treatment … -
List item
Human medicine European public assessment report (EPAR): Zirabev (updated)
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 14/02/2019,, , Revision: 5, Authorised, Last updated: 16/11/2020
medicines carboplatin and paclitaxel. The cancer improved in 45 … -
List item
Human medicine European public assessment report (EPAR): Equidacent (updated)
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell
Date of authorisation: 24/09/2020,, Revision: 1, Authorised, Last updated: 16/11/2020
with the cancer medicines paclitaxel and carboplatin. After around … -
List item
Human medicine European public assessment report (EPAR): Cyramza
Ramucirumab, Stomach Neoplasms
Date of authorisation: 19/12/2014, Revision: 11, Authorised, Last updated: 02/07/2020“Cyramza in combination with paclitaxel is indicated for the treatment … treatment in combination with paclitaxel is not appropriate (see … Cyramza in combination with paclitaxel is indicated for the treatment … -
List item
Human medicine European public assessment report (EPAR): Mekinist
trametinib, Melanoma
Date of authorisation: 30/06/2014, Revision: 19, Authorised, Last updated: 18/08/2020medicines dacarbazine or paclitaxel at controlling melanoma … patients given dacarbazine or paclitaxel. In an additional study … medicines dacarbazine or paclitaxel at controlling melanoma that … -
List item
Human medicine European public assessment report (EPAR): Keytruda (updated)
Pembrolizumab, Melanoma, Hodgkin Disease, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 17/07/2015,, Revision: 29, Authorised, Last updated: 17/11/2020
Keytruda with carboplatin and paclitaxel or nab paclitaxel lived on average for 15.9 … placebo with carboplatin and paclitaxel or nab paclitaxel. Patients in the Keytruda … -
List item
Human medicine European public assessment report (EPAR): Kanjinti
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 16/05/2018,, , Revision: 6, Authorised, Last updated: 29/11/2019
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Ogivri
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 12/12/2018,, , Revision: 3, Authorised, Last updated: 18/03/2020
other cancer medicines: with paclitaxel or docetaxel, or with another … with other cancer medicines (paclitaxel or docetaxel). A response … -
List item
Human medicine European public assessment report (EPAR): Zercepac
trastuzumab, Breast Neoplasms, Stomach Neoplasms
Date of authorisation: 27/07/2020,, , Authorised, Last updated: 28/07/2020
with other cancer medicines: paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Hycamtin
topotecan, Ovarian Neoplasms, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 12/11/1996, Revision: 30, Authorised, Last updated: 04/03/2020and compared Hycamtin with paclitaxel (another cancer medicine … compared with 14% of the paclitaxel patients (16 out of 114 … and compared Hycamtin with paclitaxel (another cancer medicine … -
List item
Human medicine European public assessment report (EPAR): Ontruzant (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 15/11/2017,, , Revision: 6, Authorised, Last updated: 10/11/2020
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Herzuma (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 08/02/2018,, , Revision: 9, Authorised, Last updated: 26/10/2020
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Trazimera
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 26/07/2018,, , Revision: 6, Authorised, Last updated: 09/07/2020
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Iressa
gefitinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 24/06/2009, Revision: 13, Authorised, Last updated: 28/05/2019combination of carboplatin and paclitaxel (other anticancer medicines … combination of carboplatin and paclitaxel (other anticancer medicines … -
List item
Human medicine European public assessment report (EPAR): Opdivo
nivolumab, Melanoma, Hodgkin Disease, Carcinoma, Renal Cell, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 19/06/2015, Revision: 32, Authorised, Last updated: 24/08/2020combination of carboplatin and paclitaxel). A third study in 906 adults … -
List item
Human medicine European public assessment report (EPAR): Yervoy (updated)
Ipilimumab, Melanoma
Date of authorisation: 12/07/2011, Revision: 34, Authorised, Last updated: 20/11/2020 -
List item
Human medicine European public assessment report (EPAR): Alimta (updated)
pemetrexed, Mesothelioma, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2004, Revision: 25, Authorised, Last updated: 27/10/2020